Rchr
J-GLOBAL ID:202101014801164034   Update date: Nov. 10, 2024

TAKAHASHI YOSHIHIRO

タカハシ ヨシヒロ | TAKAHASHI YOSHIHIRO
Affiliation and department:
Research theme for competitive and other funds  (4):
  • 2023 - 2028 Establishment of Personalized Nutritional Therapy for Prevention of Geriatric Syndrome through Community Cohort and Deep Learning
  • 2023 - 2024 ゲノム改変技術によるMODYマウスの構築
  • 2023 - 2024 ゲノム編集技術を用いたMODY再現マウスの構築
  • 未知MODY原因遺伝子同定で病的変異を立証する -オーダーメイド型マウスによる治療展開-
Papers (9):
  • Yoshihiro Takahashi, Yutaka Seino, Daisuke Yabe. Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes. Journal of diabetes investigation. 2023
  • Shohei Nishida, Takehiro Kato, Yuichi Hayashi, Shoya Yamada, Hironori Fujii, Michi Yamada, Nao Asai, Shinya Shimizu, Takashi Niwa, Hirotoshi Iihara, et al. Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus. Journal of diabetes investigation. 2023. 14. 10. 1202-1208
  • Yoshihiro Takahashi, Masanori Murayama, Kaoru Noda, Kengo Yamakawa, Yuya Koide, Rie Yamada, Makoto Hayashi, Keigo Yasuda. Cefcapene pivoxil-induced hypocarnitinemic hypoglycemia in elderly man with subclinical ACTH deficiency: a case report. BMC endocrine disorders. 2023. 23. 1. 52-52
  • Sodai Kubota, Takuya Haraguchi, Hitoshi Kuwata, Yusuke Seino, Kenta Murotani, Takumi Tajima, Gen Terashima, Makiko Kaneko, Yoshihiro Takahashi, Ken Takao, et al. Association of dipeptidyl peptidase-4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan. Journal of diabetes investigation. 2023. 14. 1. 67-74
  • Kaoru Noda, Takehiro Kato, Nao Nomura, Mayu Sakai, Sodai Kubota, Tokuyuki Hirose, Yanyan Liu, Yoshihiro Takahashi, Ken Takao, Masami Mizuno, et al. Semaglutide is effective in type 2 diabetes and obesity with schizophrenia. Diabetology international. 2022. 13. 4. 693-697
more...
MISC (1):
  • 堀谷愛美, 髙橋佳大, 窪田創大, 加藤丈博, 矢部大介. 高齢糖尿病患者におけるSGLT2阻害薬の期待と注意点-心血管・腎イベントに対する効果-. Progress in medicine. 2021. in press. 9. 805-810
Books (1):
  • 内科
    株式会社南江堂 2024
Lectures and oral presentations  (14):
  • Integrated Machine Learning Approach for MODY Diagnosis Tailored to the Japanese Population
    (2024)
  • Four cases of genetic diagnosis of Syndrome of resistance to thyroid hormone, one with a novel variant
    (2024)
  • A case of MEN1 with pulmonary NET diagnosed by cancer multi-gene panel testing of scalp metastases
    (Human Genetics Asia 2023 2023)
  • 自律型ロボットtemi®の導入とスマートホスピタルへの展開
    (第23回日本糖尿病インフォマティクス学会年次学術集会 2023)
  • Efficacy of SGLT2 inhibitors in elderly type 2 diabetes with and without renal dysfunction
    (The IDF-WPR Congress 2023 / 15th Scientific Meeting of AASD 2023)
more...
Education (2):
  • 2020 - Gifu University Graduate School of Medicine Department of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology
  • 2005 - 2011 Gifu University School of Medicine Medical Course
Professional career (1):
  • Bachelor (Gifu University)
Work history (6):
  • 2021/11 - 現在 岐阜大学医学部附属病院 糖尿病代謝内科/免疫・内分泌内科 臨床講師
  • 2017/06 - 2021/10 松波総合病院 糖尿病・内分泌内科 医員
  • 2014/04 - 2017/05 高山赤十字病院 内科 医員
  • 2013/08 - 2014/03 岐阜赤十字病院 甲状腺・糖尿病内科 医員
  • 2013/04 - 2013/07 岐阜大学医学部附属病院 糖尿病代謝内科/免疫・内分泌内科 医員
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page